Shagun Singh

Stock Analyst at RBC Capital

(2.52)
# 2,394
Out of 5,030 analysts
230
Total ratings
50%
Success rate
-0.72%
Average return

Stocks Rated by Shagun Singh

Becton, Dickinson and Company
Oct 16, 2025
Reiterates: Sector Perform
Price Target: $211
Current: $188.49
Upside: +11.94%
Abbott Laboratories
Oct 16, 2025
Reiterates: Outperform
Price Target: $147
Current: $128.28
Upside: +14.59%
Boston Scientific
Sep 29, 2025
Reiterates: Outperform
Price Target: $125
Current: $99.08
Upside: +26.17%
Outset Medical
Aug 19, 2025
Reiterates: Sector Perform
Price Target: $22
Current: $13.16
Upside: +67.17%
Intuitive Surgical
Aug 19, 2025
Reiterates: Outperform
Price Target: $615
Current: $444.24
Upside: +38.44%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $112$115
Current: $101.15
Upside: +13.69%
Insulet
Aug 8, 2025
Maintains: Outperform
Price Target: $330$350
Current: $319.37
Upside: +9.59%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Outperform
Price Target: $45$25
Current: $14.67
Upside: +70.42%
Inspire Medical Systems
Aug 5, 2025
Maintains: Outperform
Price Target: $215$180
Current: $77.78
Upside: +131.42%
Teleflex
Aug 1, 2025
Maintains: Sector Perform
Price Target: $130$135
Current: $127.63
Upside: +5.77%
Maintains: Outperform
Price Target: $330$325
Current: $251.36
Upside: +29.30%
Maintains: Outperform
Price Target: $85$89
Current: $74.17
Upside: +19.99%
Maintains: Outperform
Price Target: $181$185
Current: $192.63
Upside: -3.96%
Maintains: Sector Perform
Price Target: $4$3
Current: $1.30
Upside: +130.77%
Maintains: Outperform
Price Target: $105$101
Current: $95.19
Upside: +6.10%
Maintains: Outperform
Price Target: $425$435
Current: $372.95
Upside: +16.64%
Maintains: Outperform
Price Target: $80$92
Current: $59.33
Upside: +55.06%
Maintains: Outperform
Price Target: $120$115
Current: $66.23
Upside: +73.64%